The Therapeutic Goods Administration (TGA) has approved the use of the Pfizer vaccine in children aged 12 to 15 years.

The Technical Advisory Group on Immunisation (ATAGI) will now consider this approval and provide expert advice on which groups of adolescents should be prioritised for the roll out of the vaccine and how and when it should be administered.

To read the statement in full, please click on the link below:
TGA approves Pfizer COVID-19 vaccine for 12 to 15-year-olds